Published in Eur J Biochem on November 01, 1967
Granuloma formation induced in mice by chemically defined mycobacterial fractions. J Bacteriol (1969) 2.36
Mycobacterial lipids: selected topics. Bacteriol Rev (1972) 2.35
Acute granulomatous response produced in mice by trehalose-6,6-dimycolate. J Bacteriol (1968) 1.70
Molecular packing of cord factor and its interaction with phosphatidylinositol in mixed monolayers. Biophys J (1996) 0.87
Three types of mycolic acid from Mycobacterium tuberculosis Brévanne: implications for structure-function relationships in pathogenesis. J Bacteriol (1979) 0.85
Minimal structural requirements for adjuvant activity of bacterial peptidoglycan derivatives. Biochem Biophys Res Commun (1974) 6.53
Enhancement of nonspecific immunity to Klebsiella pneumoniae infection by a synthetic immunoadjuvant (N-acetylmuramyl-L-alanyl-D-isoglutamine) and several analogs. Proc Natl Acad Sci U S A (1977) 3.31
Insertion of long term central venous catheters: time for a new look. BMJ (1995) 2.92
Modulation of the immune response by a synthetic adjuvant and analogs. Proc Natl Acad Sci U S A (1976) 2.82
Myeloperoxidase and elastase as markers of leukocyte activation during cardiopulmonary bypass in humans. J Thorac Cardiovasc Surg (1991) 2.62
The future of interventional radiology--does it have one? Clin Radiol (1993) 2.57
The origin and function of some methyl groups in branched-chain fatty acids, plant sterols and quinones. Biochem J (1964) 2.56
Isolation and properties of a macromolecular, water-soluble, immuno-adjuvant fraction from the cell wall of Mycobacterium smegmatis. Proc Natl Acad Sci U S A (1972) 2.41
Granuloma formation induced in mice by chemically defined mycobacterial fractions. J Bacteriol (1969) 2.36
Intravenous cholangiography revisited. Clin Radiol (1993) 1.99
The mycobacterial cell wall. Pure Appl Chem (1971) 1.90
Adjuvant activity of monomeric bacterial cell wall peptidoglycans. Biochem Biophys Res Commun (1974) 1.82
Occurrence of D-alanyl-(D)-meso-diaminopimelic acid and meso-diaminopimelyl-meso-diaminopimelic acid interpeptide linkages in the peptidoglycan of Mycobacteria. Biochemistry (1974) 1.79
Immune response to sheep red blood cells in mice pretreated with mycobacterial fractions. Infect Immun (1971) 1.79
Cellular reaction in the footpad and draining lymph nodes of mice induced by mycobacterial fractions and BCG bacilli. Infect Immun (1971) 1.77
Biological activity of a new synthetic muramyl peptide adjuvant devoid of pyrogenicity. Infect Immun (1982) 1.73
Occurrence of N-glycolylmuramic acid in bacterial cell walls. A preliminary survey. Biochim Biophys Acta (1970) 1.73
Tim23 links the inner and outer mitochondrial membranes. Cell (2000) 1.68
Self-expanding metal stents for the palliation of dysphagia due to inoperable oesophageal carcinoma. Br J Surg (1995) 1.66
Fate of the synthetic immunoadjuvant, muramyl dipeptide (14C-labelled) in the mouse. Int J Immunopharmacol (1979) 1.65
Total synthesis and adjuvant activity of bacterial peptidoglycan derivatives. Biochem Biophys Res Commun (1975) 1.64
Nitric oxide synthase induces macrophage death by apoptosis. Biochem Biophys Res Commun (1993) 1.63
Use of stents for treating obstruction of urinary outflow in patients unfit for surgery. BMJ (1989) 1.62
Correlation of structure and adjuvant activity of N-acetyl muramyl-L-alanyl-D-isoglutamine (MDP), its derivatives and analogues. Anti-adjuvant and competition properties of stereoisomers. Biochem Biophys Res Commun (1976) 1.60
[Mass spectometry of glycolipids. I. Structure of the "cord factor" of Corynebacterium diphtheriae]. Eur J Biochem (1967) 1.58
Measures to prevent TRALI. Vox Sang (2007) 1.58
[N-methylation of peptides by the method of Hakomori. Structure of mycoside Cbl]. Tetrahedron Lett (1968) 1.55
Cell walls of Mycobacteria and related organisms; chemistry and immunostimulant properties. Mol Cell Biochem (1975) 1.55
Synthetic immunostimulants derived from the bacterial cell wall. J Med Chem (1980) 1.54
Isolation of mitogenic and adjuvant active fractions from various species of Nocardiae. Infect Immun (1975) 1.54
Brittle cornea. A familial trait associated with blue sclera. Am J Ophthalmol (1968) 1.53
Cord factor and related trehalose esters. Chem Phys Lipids (1976) 1.52
Chemical structure of the cell wall of Mycobacterium smegmatis. I. Isolation and partial characterization of the peptidoglycan. Biochem Biophys Res Commun (1969) 1.48
Registration of freehand 3D ultrasound and magnetic resonance liver images. Med Image Anal (2004) 1.44
Dichromats detect colour-camouflaged objects that are not detected by trichromats. Proc Biol Sci (1992) 1.43
Muramyl peptides: immunomodulators, sleep factors, and vitamins. Med Res Rev (1984) 1.40
Mitogenic effect of a water-soluble extract of Nocardia opaca: a comparative study with some bacterial adjuvants on spleen and peripheral lymphocytes of four mammalian species. J Immunol (1974) 1.40
Cerebral mass lesions in patients with AIDS. BMJ (1990) 1.40
Interventional radiology in palliative medicine. Br J Hosp Med (1997) 1.38
Diagnostic iodised oil embolisation of liver tumours--the Hammersmith experience. Eur J Radiol (1993) 1.38
Trans-oral embolization of a post-operative duodenocutaneous fistula. Clin Radiol (2004) 1.38
Preparation and biological properties of water-soluble adjuvant fractions from delipidated cells of Mycobacterium smegmatis and Nocardia opaca. Infect Immun (1973) 1.35
Mass spectrometric studies of peptides. 3. Automated determination of amino acid sequences. J Am Chem Soc (1966) 1.35
Apparent deficiency of hexosaminidase A in healthy members of a family with Tay-Sachs disease. Am J Hum Genet (1973) 1.35
Antimalarial activity of S-isobutyl adenosine against Plasmodium falciparum in culture. FEBS Lett (1978) 1.33
Immunotherapy of Cancer with Nonliving BCG and Fractions Derived from Mycobacteria: Role of Cord Factor (Trehalose-6, 6'-Dimycolate) in Tumor Regression. Infect Immun (1974) 1.31
Spinocerebellar ataxia type 2 with parkinsonism in ethnic Chinese. Neurology (2000) 1.31
Parathyroid hormone leads to the lysosomal degradation of the renal type II Na/Pi cotransporter. Proc Natl Acad Sci U S A (1998) 1.29
Inhibitory activity of sinefungin and SIBA (5'-deoxy-5'-S-isobutylthio-adenosine) on the growth of promastigotes and amastigotes of different species of Leishmania. FEBS Lett (1980) 1.28
Sulfolipid I of Mycobacterium tuberculosis, strain H37RV. Nature of the acyl substituents. Biochemistry (1971) 1.27
Stimulation of thymocyte mitogenic protein secretion and of cytostatic activity of mouse peritoneal macrophages by trehalose dimycolate and muramyldipeptide. Eur J Immunol (1980) 1.27
Molar absorptivities of beta-NADH and beta-NADPH. Clin Chem (1976) 1.26
From cradle to early grave: juvenile mortality in European shags Phalacrocorax aristotelis results from inadequate development of foraging proficiency. Biol Lett (2007) 1.25
Apyrogenic, adjuvant-active N-acetylmuramyl-dipeptides. J Med Chem (1982) 1.25
Mass spectrometry of plastoquinones. The structure of the plastoquinones B,C and D. Biochem Biophys Res Commun (1965) 1.24
Linkage relations of X-borne ichthyosis to the Xg blood groups and to other markers of the X in Israelis. Ann Hum Genet (1969) 1.23
The antifungal antibiotic sinefungin as a very active inhibitor of methyltransferases and of the transformation of chick embryo fibroblasts by Rous sarcoma virus. Biochem Biophys Res Commun (1978) 1.22
Antitrypanosomal activity of sinefungin. Am J Trop Med Hyg (1983) 1.22
Silica induces apoptosis in macrophages and the release of interleukin-1 alpha and interleukin-1 beta. J Leukoc Biol (1993) 1.21
Immunostimulant activities of a lipophilic muramyl dipeptide derivative and of desmuramyl peptidolipid analogs. Infect Immun (1980) 1.21
Bradykinin and des-Arg(9)-bradykinin metabolic pathways and kinetics of activation of human plasma. Am J Physiol Heart Circ Physiol (2001) 1.21
Plastic-covered metallic endoprostheses in the management of oesophageal perforation in patients with oesophageal carcinoma. Clin Radiol (1995) 1.20
Patterns of genetic diversity in outcrossing and selfing populations of Arabidopsis lyrata. Mol Ecol (2007) 1.20
Glucose-6-phosphate dehydrogenase mosaicism as a tracer in the study of hereditary multiple trichoepithelioma. Am J Hum Genet (1966) 1.19
Muramyl peptides. Chemical structure, biological activity and mechanism of action. Mol Cell Biochem (1981) 1.19
Inhibition of caspase activity induces a switch from apoptosis to necrosis. FEBS Lett (1998) 1.19
Gianturco expandable metallic biliary stents: results of a European clinical trial. Radiology (1989) 1.19
Structure of iturine A, a peptidolipid antibiotic from Bacillus subtilis. Biochemistry (1978) 1.18
Presence and subcellular localization of two distinct mitogenic fractions in the cells of Nocardia rubra and Nocardia opaca: preparation of soluble mitogenic peptidoglycan fractions. Infect Immun (1976) 1.18
Metallic stents in malignant biliary obstruction: results of a multicenter European study of 240 patients. J Vasc Interv Radiol (1994) 1.17
Use of metallic stents and balloons in the esophagus and gastrointestinal tract. J Vasc Interv Radiol (2001) 1.15
Natural and synthetic trehalose diesters as immunomodulators. Med Res Rev (1986) 1.14
Dubin-Johnson syndrome in Israel. I. Clinical, laboratory, and genetic aspects of 101 cases. Q J Med (1970) 1.14
Relationship between chemical structure and adjuvant activity of some synthetic analogues of N-acetyl-muramyl-L-alanyl-D-isoglutamine (MDP). Ann Immunol (Paris) (1977) 1.13
Ganglioneuroblastoma of the posterior mediastinum: a clinicopathologic review of 80 cases. Cancer (1981) 1.12
Immunotherapy with an intralesionally administered synthetic cord factor analogue. Int J Cancer (1978) 1.11
Monarticular brucellar arthritis in children. J Bone Joint Surg Br (1967) 1.11
[On the structure of the alpha-mycolic acids of the human test strain of Mycobacterium tuberculosis]. Bull Soc Chim Fr (1965) 1.10
Influence of vasopressin on learning and memory. Lancet (1978) 1.10
Parathyroid hormone-dependent degradation of type II Na+/Pi cotransporters. J Biol Chem (1997) 1.10
Nonspecific immunostimulant activities of synthetic trehalose-6,6'-diesters (lower homologs of cord factor). Infect Immun (1978) 1.08